Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors
© 2020 National Institutes of Health. Publishing services by Atlantis Press International B.V..
Long-term allogeneic hematopoietic cell transplant (allo-HCT) survivors suffer an elevated risk of coronary heart disease (CHD). We conducted a prospective, nonrandomized, cross-sectional study to screen asymptomatic survivors at a single allo-HCT center using cardiac computed tomography (CT) involving coronary CT angiography (CCTA) and the coronary artery calcium (CAC) score. Seventy-nine subjects with a median age of 39 years at allo-HCT and a median follow-up interval of 8 years were evaluated for CHD by Framingham Risk Score (FRS) and cardiac CT. CHD was detected in 33 of 79 (42%) subjects; 91% of lesions were nonobstructive, 19.5% of were noncalcified and 30% had associated valvular calcification. Overall, CAC was significantly superior to FRS in detecting early CHD in allo-HCT survivors [∆C = 0.25; P < 0.0001]. While both FRS and CAC were highly, >95% specific, FRS had a sensitivity, positive and negative predictive values of only 28% (95% CI, 14%-47%), 90% (95% CI, 55%-100%) and 60% (95% CI, 47%-73%), respectively. In contrast, the sensitivity, positive and negative predictive values of CAC were 78% (95% CI, 60%-91%), 96% (95% CI, 80%-100%) and 83% (95% CI, 69%-93%), respectively. Significantly, cardiac CT detected CHD in 23 of the 68 (34%) survivors deemed to have a low Framingham risk. Radiation exposure during cardiac CT was negligible, and there were no adverse events. In conclusion, CAC score with or without CCTA is a safe, feasible and sensitive screening technique for CHD. The FRS greatly underestimates CHD in allo-HCT survivors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
Clinical hematology international - 2(2020), 3 vom: 24. Sept., Seite 109-116 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jain, Natasha A [VerfasserIn] |
---|
Links: |
---|
Themen: |
BMT |
---|
Anmerkungen: |
Date Revised 02.10.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2991/chi.d.200508.001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM331368811 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM331368811 | ||
003 | DE-627 | ||
005 | 20231225213316.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2991/chi.d.200508.001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1104.xml |
035 | |a (DE-627)NLM331368811 | ||
035 | |a (NLM)34595451 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jain, Natasha A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 02.10.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2020 National Institutes of Health. Publishing services by Atlantis Press International B.V. | ||
520 | |a Long-term allogeneic hematopoietic cell transplant (allo-HCT) survivors suffer an elevated risk of coronary heart disease (CHD). We conducted a prospective, nonrandomized, cross-sectional study to screen asymptomatic survivors at a single allo-HCT center using cardiac computed tomography (CT) involving coronary CT angiography (CCTA) and the coronary artery calcium (CAC) score. Seventy-nine subjects with a median age of 39 years at allo-HCT and a median follow-up interval of 8 years were evaluated for CHD by Framingham Risk Score (FRS) and cardiac CT. CHD was detected in 33 of 79 (42%) subjects; 91% of lesions were nonobstructive, 19.5% of were noncalcified and 30% had associated valvular calcification. Overall, CAC was significantly superior to FRS in detecting early CHD in allo-HCT survivors [∆C = 0.25; P < 0.0001]. While both FRS and CAC were highly, >95% specific, FRS had a sensitivity, positive and negative predictive values of only 28% (95% CI, 14%-47%), 90% (95% CI, 55%-100%) and 60% (95% CI, 47%-73%), respectively. In contrast, the sensitivity, positive and negative predictive values of CAC were 78% (95% CI, 60%-91%), 96% (95% CI, 80%-100%) and 83% (95% CI, 69%-93%), respectively. Significantly, cardiac CT detected CHD in 23 of the 68 (34%) survivors deemed to have a low Framingham risk. Radiation exposure during cardiac CT was negligible, and there were no adverse events. In conclusion, CAC score with or without CCTA is a safe, feasible and sensitive screening technique for CHD. The FRS greatly underestimates CHD in allo-HCT survivors | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a BMT | |
650 | 4 | |a Coronary CT angiogram | |
650 | 4 | |a cardiovascular risk | |
650 | 4 | |a late effects | |
650 | 4 | |a survivorship | |
700 | 1 | |a Chen, Marcus Y |e verfasserin |4 aut | |
700 | 1 | |a Shanbhag, Sujata |e verfasserin |4 aut | |
700 | 1 | |a Anandi, Prathima |e verfasserin |4 aut | |
700 | 1 | |a Tian, Xin |e verfasserin |4 aut | |
700 | 1 | |a Ito, Sawa |e verfasserin |4 aut | |
700 | 1 | |a Pophali, Priyanka A |e verfasserin |4 aut | |
700 | 1 | |a Doucette, Kimberly |e verfasserin |4 aut | |
700 | 1 | |a Le, Robert Q |e verfasserin |4 aut | |
700 | 1 | |a Chawla, Upneet |e verfasserin |4 aut | |
700 | 1 | |a Koklanaris, Eleftheria |e verfasserin |4 aut | |
700 | 1 | |a Childs, Richard W |e verfasserin |4 aut | |
700 | 1 | |a Barrett, A John |e verfasserin |4 aut | |
700 | 1 | |a Battiwalla, Minoo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical hematology international |d 2019 |g 2(2020), 3 vom: 24. Sept., Seite 109-116 |w (DE-627)NLM307772861 |x 2590-0048 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2020 |g number:3 |g day:24 |g month:09 |g pages:109-116 |
856 | 4 | 0 | |u http://dx.doi.org/10.2991/chi.d.200508.001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2 |j 2020 |e 3 |b 24 |c 09 |h 109-116 |